BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 14973407)

  • 21. Ovulation induction management of PCOS.
    Guzick DS
    Clin Obstet Gynecol; 2007 Mar; 50(1):255-67. PubMed ID: 17304040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin for the treatment of the polycystic ovary syndrome.
    Barbieri RL; Gargiulo AR
    Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive impact of polycystic ovary syndrome.
    Usadi RS; Legro RS
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):505-11. PubMed ID: 23108198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovulation induction in the management of anovulatory polycystic ovary syndrome.
    Balen AH
    Mol Cell Endocrinol; 2013 Jul; 373(1-2):77-82. PubMed ID: 23084977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and therapy of polycystic ovarian syndrome.
    Loy R; Seibel MM
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):785-813. PubMed ID: 3143568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
    Saleh AM; Khalil HS
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel strategies in the management of polycystic ovary syndrome.
    Spritzer PM; Motta AB; Sir-Petermann T; Diamanti-Kandarakis E
    Minerva Endocrinol; 2015 Sep; 40(3):195-212. PubMed ID: 25781065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Hum Reprod; 2008 Mar; 23(3):462-77. PubMed ID: 18308833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.
    Palomba S; Falbo A; Zullo F
    Curr Opin Obstet Gynecol; 2009 Dec; 21(6):465-73. PubMed ID: 19809318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A; Yogev Y; Fisch B
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis.
    Kulshreshtha B; Gupta N; Ganie MA; Ammini AC
    Gynecol Endocrinol; 2012 Oct; 28(10):823-6. PubMed ID: 22475072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Morgante G; Massaro MG; Di Sabatino A; Cappelli V; De Leo V
    Gynecol Endocrinol; 2018 Jan; 34(1):4-9. PubMed ID: 28850273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome.
    Baran S; Api M; Goksedef BP; Cetin A
    Arch Gynecol Obstet; 2010 Oct; 282(4):439-43. PubMed ID: 20473763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
    Muenstermann U; Kleinstein J
    Hum Reprod; 2000 Dec; 15(12):2526-30. PubMed ID: 11098021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.